CASE STUDY
Workflow Automation of New Cell-Based Therapies
Strategic evaluation of the cell-based therapy market and need for automation
Commercial Issue
Thinking
Approach
Results
Engineering-driven life science automation company wanted to develop solutions for the emerging cell-therapy market. Would the market be large enough to build a business?
Significant investment into the cell-therapy market over the last decade. Will investment translate into commercial opportunities? If the addressable market is sufficiently large, what are the specific opportunities for investment available to the company?
-
In-depth interviews with industry experts to understand the potential uses of automation in the cold chain to address unmet needs and bottlenecks
-
Bottoms-up model development and forecasts for market sizing and growth
-
End-to-end workflows indicated the location of the greatest need for automation in the cold chain
-
Provided market opportunity assessment based on addressable needs
-
Created a partnership and acquisition roadmap for the next
5 years -
Company invested/partnered in areas CBA identified as greatest opportunity and exceeded original plan over the last 3 years